Endocrine oncology

Disparities in Initial Thyroid Cancer Care by Hospital Treatment Volume: Analysis of 52,599 Cases in California

ThyroidPublished Retrospective cohort study

Authors' conclusion

Patients receiving thyroid cancer surgery at centers performing ≤5 such operations per year were more likely to require reoperation for recurrent/persistent disease and less likely to receive appropriate 131I ablation. Ultra-low volume centers served higher proportions of socially and economically marginalized communities.

Study context

Population
Thyroid cancer patients who received thyroid surgery in California, 1999–2017
Participants
52,599 patients
Exposure
Thyroid cancer surgery at ultra-low vs low-, mid- and high-volume hospitals
Outcome
Reoperation for recurrent/persistent disease
Methodological detailspopulation-based, linked California Cancer Registry and OSHPD databases, multivariable regression
  • Population-based
  • Linked California Cancer Registry and OSHPD databases
  • Multivariable regression

Main finding

As reported in the abstract

Odds ratio (CI)
Ultra-low volumevs Low-volume
1.17(1.02–1.35)
Ultra-low volumevs Mid-volume
1.25(1.06–1.46)
Ultra-low volumevs High-volume
1.26(1.03–1.56)

Observational data: associations, not effects.

Further findings

OutcomeOR (CI)
Guideline-concordant 131I ablationUltra-low volumevs Higher volume centers0.77 (0.72–0.82)

Outcomes among low-, mid- and high-volume centers

No statistically significant differences between low-, mid- or high-volume centers; only ultra-low volume centers had significantly higher rates of adverse outcomes

Access to ultra-low vs higher volume centers by demographics

Disproportionately accessed by women
P < 0.05
Disproportionately accessed by Hispanic, Asian/Pacific Islander and American Indian people
P < 0.01
Disproportionately accessed by lowest three socio-economic quintiles
P < 0.01
Disproportionately accessed by uninsured and Medicaid or Medicare
P < 0.01

Original publication

Disparities in Initial Thyroid Cancer Care by Hospital Treatment Volume: Analysis of 52,599 Cases in California. Thyroid. Published 4 September 2023. doi:10.1089/thy.2023.0241

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.